METTL3 regulates the proliferation, metastasis and EMT progression of bladder cancer through P3H4
Authors:
- 17 November 2023
- journal article
- research article
- Published by Elsevier in Cellular Signalling
- Vol. 113, 110971
Abstract
No abstract availableKeywords
This publication has 30 references indexed in Scilit:
- METTL3-mediated N6-methyladenosine modification is critical for epithelial-mesenchymal transition and metastasis of gastric cancerMolecular Cancer, 2019
- METTL3-mediated m 6 A modification of HDGF mRNA promotes gastric cancer progression and has prognostic significanceGut, 2019
- METTL3 promote tumor proliferation of bladder cancer by accelerating pri-miR221/222 maturation in m6A-dependent mannerMolecular Cancer, 2019
- Epithelial-Mesenchymal Plasticity in Cancer Progression and MetastasisDevelopmental Cell, 2019
- EMT Transition States during Tumor Progression and MetastasisTrends in Cell Biology, 2019
- The m6A methyltransferase METTL3 promotes bladder cancer progression via AFF4/NF-κB/MYC signaling networkOncogene, 2019
- Epigenetic Mechanisms Influencing Epithelial to Mesenchymal Transition in Bladder CancerInternational Journal of Molecular Sciences, 2019
- EFEMP2 suppresses epithelial-mesenchymal transition via Wnt/β-catenin signaling pathway in human bladder cancerInternational Journal of Biological Sciences, 2019
- New insights into the mechanisms of epithelial–mesenchymal transition and implications for cancerNature Reviews Molecular Cell Biology, 2018
- P3H4 is correlated with clinicopathological features and prognosis in bladder cancerWorld Journal of Surgical Oncology, 2018